Analysis of SARS-CoV-2 viral loads in stool samples and nasopharyngeal swabs from COVID-19 patients in the United Arab Emirates.

Coronavirus disease 2019 (COVID-19) was first identified in respiratory samples and was found to commonly cause cough and pneumonia. However, non-respiratory symptoms including gastrointestinal disorders are also present and a big proportion of patients test positive for the virus in stools for a pr...

Full description

Bibliographic Details
Main Authors: Mariane Daou, Hussein Kannout, Mariam Khalili, Mohamed Almarei, Mohamed Alhashami, Zainab Alhalwachi, Fatima Alshamsi, Mohammad Tahseen Al Bataineh, Mohd Azzam Kayasseh, Abdulmajeed Al Khajeh, Shadi W Hasan, Guan K Tay, Samuel F Feng, Dymitr Ruta, Ahmed F Yousef, Habiba S Alsafar, UAE COVID-19 Collaborative Partnership
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2022-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0274961
_version_ 1797997194857414656
author Mariane Daou
Hussein Kannout
Mariam Khalili
Mohamed Almarei
Mohamed Alhashami
Zainab Alhalwachi
Fatima Alshamsi
Mohammad Tahseen Al Bataineh
Mohd Azzam Kayasseh
Abdulmajeed Al Khajeh
Shadi W Hasan
Guan K Tay
Samuel F Feng
Dymitr Ruta
Ahmed F Yousef
Habiba S Alsafar
UAE COVID-19 Collaborative Partnership
author_facet Mariane Daou
Hussein Kannout
Mariam Khalili
Mohamed Almarei
Mohamed Alhashami
Zainab Alhalwachi
Fatima Alshamsi
Mohammad Tahseen Al Bataineh
Mohd Azzam Kayasseh
Abdulmajeed Al Khajeh
Shadi W Hasan
Guan K Tay
Samuel F Feng
Dymitr Ruta
Ahmed F Yousef
Habiba S Alsafar
UAE COVID-19 Collaborative Partnership
author_sort Mariane Daou
collection DOAJ
description Coronavirus disease 2019 (COVID-19) was first identified in respiratory samples and was found to commonly cause cough and pneumonia. However, non-respiratory symptoms including gastrointestinal disorders are also present and a big proportion of patients test positive for the virus in stools for a prolonged period. In this cross-sectional study, we investigated viral load trends in stools and nasopharyngeal swabs and their correlation with multiple demographic and clinical factors. The study included 211 laboratory-confirmed cases suffering from a mild form of the disease and completing their isolation period at a non-hospital center in the United Arab Emirates. Demographic and clinical information was collected by standardized questionnaire and from the medical records of the patient. Of the 211 participants, 25% tested negative in both sample types at the time of this study and 53% of the remaining patients had detectable viral RNA in their stools. A positive fecal viral test was associated with male gender, diarrhea as a symptom, and hospitalization during infection. A positive correlation was also observed between a delayed onset of symptoms and a positive stool test. Viral load in stools positively correlated with, being overweight, exercising, taking antibiotics in the last 3 months and blood type O. The viral load in nasopharyngeal swabs, on the other hand, was higher for blood type A, and rhesus positive (Rh factor). Regression analysis showed no correlation between the viral loads measured in stool and nasopharyngeal samples in any given patient. The results of this work highlight the factors associated with a higher viral count in each sample. It also shows the importance of stool sample analysis for the follow-up and diagnosis of recovering COVID-19 patients.
first_indexed 2024-04-11T10:29:17Z
format Article
id doaj.art-74fb312d9ddf43dfb695ed793c9bfb97
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-04-11T10:29:17Z
publishDate 2022-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-74fb312d9ddf43dfb695ed793c9bfb972022-12-22T04:29:28ZengPublic Library of Science (PLoS)PLoS ONE1932-62032022-01-01179e027496110.1371/journal.pone.0274961Analysis of SARS-CoV-2 viral loads in stool samples and nasopharyngeal swabs from COVID-19 patients in the United Arab Emirates.Mariane DaouHussein KannoutMariam KhaliliMohamed AlmareiMohamed AlhashamiZainab AlhalwachiFatima AlshamsiMohammad Tahseen Al BatainehMohd Azzam KayassehAbdulmajeed Al KhajehShadi W HasanGuan K TaySamuel F FengDymitr RutaAhmed F YousefHabiba S AlsafarUAE COVID-19 Collaborative PartnershipCoronavirus disease 2019 (COVID-19) was first identified in respiratory samples and was found to commonly cause cough and pneumonia. However, non-respiratory symptoms including gastrointestinal disorders are also present and a big proportion of patients test positive for the virus in stools for a prolonged period. In this cross-sectional study, we investigated viral load trends in stools and nasopharyngeal swabs and their correlation with multiple demographic and clinical factors. The study included 211 laboratory-confirmed cases suffering from a mild form of the disease and completing their isolation period at a non-hospital center in the United Arab Emirates. Demographic and clinical information was collected by standardized questionnaire and from the medical records of the patient. Of the 211 participants, 25% tested negative in both sample types at the time of this study and 53% of the remaining patients had detectable viral RNA in their stools. A positive fecal viral test was associated with male gender, diarrhea as a symptom, and hospitalization during infection. A positive correlation was also observed between a delayed onset of symptoms and a positive stool test. Viral load in stools positively correlated with, being overweight, exercising, taking antibiotics in the last 3 months and blood type O. The viral load in nasopharyngeal swabs, on the other hand, was higher for blood type A, and rhesus positive (Rh factor). Regression analysis showed no correlation between the viral loads measured in stool and nasopharyngeal samples in any given patient. The results of this work highlight the factors associated with a higher viral count in each sample. It also shows the importance of stool sample analysis for the follow-up and diagnosis of recovering COVID-19 patients.https://doi.org/10.1371/journal.pone.0274961
spellingShingle Mariane Daou
Hussein Kannout
Mariam Khalili
Mohamed Almarei
Mohamed Alhashami
Zainab Alhalwachi
Fatima Alshamsi
Mohammad Tahseen Al Bataineh
Mohd Azzam Kayasseh
Abdulmajeed Al Khajeh
Shadi W Hasan
Guan K Tay
Samuel F Feng
Dymitr Ruta
Ahmed F Yousef
Habiba S Alsafar
UAE COVID-19 Collaborative Partnership
Analysis of SARS-CoV-2 viral loads in stool samples and nasopharyngeal swabs from COVID-19 patients in the United Arab Emirates.
PLoS ONE
title Analysis of SARS-CoV-2 viral loads in stool samples and nasopharyngeal swabs from COVID-19 patients in the United Arab Emirates.
title_full Analysis of SARS-CoV-2 viral loads in stool samples and nasopharyngeal swabs from COVID-19 patients in the United Arab Emirates.
title_fullStr Analysis of SARS-CoV-2 viral loads in stool samples and nasopharyngeal swabs from COVID-19 patients in the United Arab Emirates.
title_full_unstemmed Analysis of SARS-CoV-2 viral loads in stool samples and nasopharyngeal swabs from COVID-19 patients in the United Arab Emirates.
title_short Analysis of SARS-CoV-2 viral loads in stool samples and nasopharyngeal swabs from COVID-19 patients in the United Arab Emirates.
title_sort analysis of sars cov 2 viral loads in stool samples and nasopharyngeal swabs from covid 19 patients in the united arab emirates
url https://doi.org/10.1371/journal.pone.0274961
work_keys_str_mv AT marianedaou analysisofsarscov2viralloadsinstoolsamplesandnasopharyngealswabsfromcovid19patientsintheunitedarabemirates
AT husseinkannout analysisofsarscov2viralloadsinstoolsamplesandnasopharyngealswabsfromcovid19patientsintheunitedarabemirates
AT mariamkhalili analysisofsarscov2viralloadsinstoolsamplesandnasopharyngealswabsfromcovid19patientsintheunitedarabemirates
AT mohamedalmarei analysisofsarscov2viralloadsinstoolsamplesandnasopharyngealswabsfromcovid19patientsintheunitedarabemirates
AT mohamedalhashami analysisofsarscov2viralloadsinstoolsamplesandnasopharyngealswabsfromcovid19patientsintheunitedarabemirates
AT zainabalhalwachi analysisofsarscov2viralloadsinstoolsamplesandnasopharyngealswabsfromcovid19patientsintheunitedarabemirates
AT fatimaalshamsi analysisofsarscov2viralloadsinstoolsamplesandnasopharyngealswabsfromcovid19patientsintheunitedarabemirates
AT mohammadtahseenalbataineh analysisofsarscov2viralloadsinstoolsamplesandnasopharyngealswabsfromcovid19patientsintheunitedarabemirates
AT mohdazzamkayasseh analysisofsarscov2viralloadsinstoolsamplesandnasopharyngealswabsfromcovid19patientsintheunitedarabemirates
AT abdulmajeedalkhajeh analysisofsarscov2viralloadsinstoolsamplesandnasopharyngealswabsfromcovid19patientsintheunitedarabemirates
AT shadiwhasan analysisofsarscov2viralloadsinstoolsamplesandnasopharyngealswabsfromcovid19patientsintheunitedarabemirates
AT guanktay analysisofsarscov2viralloadsinstoolsamplesandnasopharyngealswabsfromcovid19patientsintheunitedarabemirates
AT samuelffeng analysisofsarscov2viralloadsinstoolsamplesandnasopharyngealswabsfromcovid19patientsintheunitedarabemirates
AT dymitrruta analysisofsarscov2viralloadsinstoolsamplesandnasopharyngealswabsfromcovid19patientsintheunitedarabemirates
AT ahmedfyousef analysisofsarscov2viralloadsinstoolsamplesandnasopharyngealswabsfromcovid19patientsintheunitedarabemirates
AT habibasalsafar analysisofsarscov2viralloadsinstoolsamplesandnasopharyngealswabsfromcovid19patientsintheunitedarabemirates
AT uaecovid19collaborativepartnership analysisofsarscov2viralloadsinstoolsamplesandnasopharyngealswabsfromcovid19patientsintheunitedarabemirates